Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Human Immunology|April 18, 2016
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantationIgor Salvadé, Vincent Aubert, Jean-Pierre Venetz, et al.Kidney International Reports|February 24, 2025
Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in SwitzerlandFederica Bocchi, Selina Müller, Isabelle Binet, et al.Frontiers in Pharmacology|November 30, 2019
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney InjuryJean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, et al.Plos One|March 4, 2014
Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signalingRajesh Kumar, Anne-Catherine Clerc, Ilaria Gori, et al.Novartis Foundation Symposium|November 12, 2003
Control of immune pathology by regulatory T cellsFiona Powrie, Simon Read, Christian Mottet, et al.Scientific Reports|June 11, 2024
Assessing the perioperative gain of weight (Δweight) as a determinant of morbidity after kidney transplantation: a retrospective exploratory studyBeatriz Barberá Carbonell, Tobias Zingg, Maurice Matter, et al.Frontiers in Immunology|November 26, 2025
Case Report: A novel approach to prevent chronic histiocytic intervillositis and recurrent pregnancy loss by targeting maternal alloimmunityMathilde Gavillet, Carole Gengler, Helene Legardeur, et al.Neurology|July 5, 2023
Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?Tristan Born, Paola Vassallo, Dela Golshayan, et al.Xenotransplantation|July 23, 2020
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantationNora Schwotzer, Giulia Paganetti, Matteo Barchi, et al.Transplantation|June 9, 2009
Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cellsHenrieta Fazekasova, Dela Golshayan, Joseph Read, et al.Pageof 14